Pediatric Infection and Vaccine

The Korean Society of Pediatric Infectious Diseases (대한소아감염학회)
권호 표지
DOI QR코드

DOI QR Code

Neonatal Sepsis and Meningitis Caused by Neisseria meningitidis Serogroup B: a Case Report

  • Kim, Yoo Na (Department of Pediatrics, Kyung Hee University Hospital, Kyung Hee University School of Medicine) ;
  • Choi, Yong-Sung (Department of Pediatrics, Kyung Hee University Hospital, Kyung Hee University School of Medicine) ;
  • Cha, Sung Ho (Department of Pediatrics, Kyung Hee University Hospital, Kyung Hee University School of Medicine)
  • Received : 2018.02.23
  • Accepted : 2018.07.18
  • Published : 2018.12.25
Download PDF
⟨ Previous Next ⟩

Abstract

Sepsis and meningitis caused by Neisseria meningitidis are rare in neonates, but neonatal sepsis and meningitis are associated with a high rate of mortality. Meningococcal disease is commonly reported in older children and adolescents and is known to be more prevalent in community settings. In this study, a 16-day-old neonate was diagnosed with serogroup B meningococcal sepsis and meningitis. The baby was treated with antibiotics at the early stages of the infection and was discharged in good condition without any complications. This case report can serve to raise awareness of the incidence and importance of meningococcal infection in neonates, especially serogroup B.

수막구균 감염은 신생아에서 높은 사망률을 보이지만 매우 드물고, 단체 생활하는 연장아나 청소년에서 더 흔하다고 알려져 있다. 이 증례에서 소개된 생후 16일 신생아는 수막구균 B 혈청군 패혈증과 수막염이 진단되었지만 조기 항생제 치료를 통해 합병증 없이 건강하게 퇴원하였다. 이 증례 보고의 목적은 신생아에서 수막구균 감염의 발생률과 중요성을 상기시키고 노출된 가족들과 의료진에 대한 조사와 예방 요법의 필요성을 강조하기 위함이다. 한국에서는 많은 신생아가 출생 후 산후조리원 시설에서 지내내므로 감염 발생과 전파에 단체 생활이 영향을 미칠 수도 있음을 생각해 볼 필요가 있다. 질병의 조기 발견, 격리, 그리고 경험적 치료가 치명적인 질병의 전파를 예방하기 위해 매우 중요하다.

Keywords

References

  1. Klein J, Marcy S. Bacterial sepsis and meningitis. In: Remington JS, Klein JO, editors. Infectious diseases of the fetus and newborn infant. 4th ed. Philadelphia (PA): Saunders; 1995:835-90.
  2. Kiray Bas E, Bulbul A, Comert S, Uslu S, Arslan S, Nuhoglu A. Neonatal infection with Neisseria meningitidis: analysis of a 97-year period plus case study. J Clin Microbiol 2014;52:3478-82. https://doi.org/10.1128/JCM.01000-14
  3. World Health Organization. Meningococcal meningitis [Internet]. Geneva: World Health Organization; 2015 [cited 2017 Dec 12]. Available from: http://www.who.int/immunization/diseases/meningitis/en/.
  4. Kliegman R, Stanton B, St Geme JW III, Schor NF, Behrman RE. Neisseria meningitidis (Meningococcus). In: Pollard AJ, Sadarangani M, editors. Nelson textbook of pediatrics. 20th ed. Philadelphia (PA): Elsevier Health Sciences; 2016:1356-65.
  5. Buckwalter CM, Currie EG, Tsang RS, Gray-Owen SD. Discordant effects of licensed meningococcal serogroup B vaccination on invasive disease and nasal colonization in a humanized mouse model. J Infect Dis 2017;215:1590-8. https://doi.org/10.1093/infdis/jix162
  6. Memish ZA, Al-Tawfiq JA, Almasri M, Azhar EI, Yasir M, Al-Saeed MS, et al. Neisseria meningitidis nasopharyngeal carriage during the Hajj: A cohort study evaluating the need for ciprofloxacin prophylaxis. Vaccine 2017;35:2473-8. https://doi.org/10.1016/j.vaccine.2017.03.027
  7. Meningococcal vaccines: WHO position paper, November 2011. Wkly Epidemiol Rec 2011;86:521-39.
  8. Bilal A, Taha MK, Caeymaex L, Cohen R, Levy C, Durrmeyer X, et al. Neonatal meningococcal meningitis in France from 2001 to 2013. Pediatr Infect Dis J 2016;35:1270-2. https://doi.org/10.1097/INF.0000000000001296
  9. MacNeil JR, Meyer SA. Meningococcal disease [Internet]. Atlanta (GA): Centers for Disease Control and Prevention; 2017 [cited 2017 Jan 3]. Available from: https://wwwnc.cdc.gov/travel/yellowbook/2016/infectious-diseases-related-to-travel/meningococcal-disease.
  10. Parikh SR, Andrews NJ, Beebeejaun K, Campbell H, Ribeiro S, Ward C, et al. Effectiveness and impact of a reduced infant schedule of 4CMenB vaccine against group B meningococcal disease in England: a national observational cohort study. Lancet 2016;388:2775-82. https://doi.org/10.1016/S0140-6736(16)31921-3
  11. Whittaker R, Dias JG, Ramliden M, Kodmon C, Economopoulou A, Beer N, et al. The epidemiology of invasive meningococcal disease in EU/EEA countries, 2004-2014. Vaccine 2017;35:2034-41. https://doi.org/10.1016/j.vaccine.2017.03.007
  12. Feavers IM, Maiden MC. Recent progress in the prevention of serogroup B meningococcal disease. Clin Vaccine Immunol 2017;24:e00566-16.
  13. The Korean Pediatric Society. Neisseria meningitidis vaccine. In: Kim KH, editor. Immunization guideline. 8th ed. Seoul: The Korean Pediatric Society; 2015:253-70.
  14. Centers for Disease Control and Prevention. Meningococcal disease: risk factors. Atlanta (GA): Centers for Disease Control and Prevention; 2017 [cited 2018 Jan 3]. Available from: https://www.cdc.gov/meningococcal/about/risk-factors.html.

Cited by

  1. ANALYSIS OF SOCIAL AND MEDICAL PORTRAIT OF CHILDREN WITH PERTUSSIS, MENINGOCOCCAL INFECTIOUS, SCARLET FEVER AND ESTIMATION OF THEIR ASSIGNED PHARMACOTHERAPY vol.72, pp.9, 2019, https://doi.org/10.36740/wlek201909218